Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Publisher Correction: Zeb2 drives invasive and microbiota-dependent colon carcinoma

The Original Article was published on 15 June 2020

Correction to: Nature Cancer, published online 15 June 2020.

In the version of this article initially published, affiliations for several authors (David Nittner, Pieter Van Vlierberghe, Gert De Hertogh, Pamela Baldin, Emre Etlioglu, Sabine Tejpar, Steven Goossens and Lars Vereecke) were incorrect or missing. The correct authors and affiliations are as follows:

Karolina Slowicka1,2,3,21, Ioanna Petta1,3,4,21, Gillian Blancke1,3,4, Esther Hoste1,2, Emilie Dumas1,3,4, Mozes Sze1,2, Hanna Vikkula1,2, Enrico Radaelli5,6, Jody J. Haigh7,8, Sven Jonckheere2,9, Joachim Taminau2,9, Niels Vandamme1,2,9, Andy Wullaert1,2,3,4, Eugene Tulchinsky10,11, David Nittner12,13, Pieter Van Vlierberghe9,14, Gert De Hertogh15, Pamela Baldin16, Emre Etlioglu13, Pratyaksha Wirapati17, Louis Boon18, Bart N. Lambrecht1,4, Chris Callewaert19, Sabine Tejpar13, Steven Goossens2,9,14,20, Geert Berx2,9,22, Lars Vereecke1,3,4,9,22 and Geert van Loo1,2,3,9,22

1VIB Center for Inflammation Research, Ghent, Belgium. 2Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. 3Ghent Gut Inflammation Group, Ghent University, Ghent, Belgium. 4Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium. 5KU Leuven Center for Human Genetics, Leuven, Belgium. 6VIB Center for Brain & Disease Research, Leuven, Belgium. 7Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada. 8Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. 9Cancer Research Institute Ghent, Ghent, Belgium. 10University of Leicester, Leicester, UK. 11Department of Biomedical Sciences, Nazarbayev University School of Medicine, Astana, Kazakhstan. 12Histopathology Expertise Center, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium. 13Department of Oncology, University Hospital Leuven, KU Leuven, Leuven, Belgium. 14Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. 15Department of Pathology, University Hospital Leuven, KU Leuven, Leuven, Belgium. 16Department of Pathology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium. 17Swiss Institute of Bioinformatics, Lausanne, Switzerland. 18Bioceros, Utrecht, the Netherlands. 19Center for Microbial Ecology and Technology, Ghent University, Ghent, Belgium. 20Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. 21These authors contributed equally: Karolina Slowicka, Ioanna Petta. 22These authors jointly supervised this work: Geert Berx, Lars Vereecke, Geert van Loo.

The errors have been corrected in the HTML and PDF versions of the article.

Author information



Corresponding authors

Correspondence to Geert Berx, Lars Vereecke or Geert van Loo.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Slowicka, K., Petta, I., Blancke, G. et al. Publisher Correction: Zeb2 drives invasive and microbiota-dependent colon carcinoma. Nat Cancer 1, 750 (2020).

Download citation


Quick links